Angiotech Sells Interventional Products Business to Argon Medical Devices, Inc.

Angiotech Pharmaceuticals, Inc. has entered into a definitive agreement to sell certain of its subsidiaries, comprising Angiotech’s Interventional Products Business, to Argon Medical Devices, Inc., for $362.5 million in cash consideration. Angiotech expects the transaction will close prior to the end of April 2013.

Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc. (via PR Newswire)

VANCOUVER, March 25, 2013 /PRNewswire/ – Angiotech Pharmaceuticals, Inc. (“Angiotech”) announced today that it had entered into a definitive agreement to sell certain of its subsidiaries, comprising Angiotech’s Interventional Products Business, to Argon Medical Devices, Inc. (“Argon”), a portfolio…

published: March 25, 2013 in: Cardio, Mergers and Acquisitions

Most read

Latest

^